You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Former Biden Aide Admits Staff Felt Justified Doing 'Undemocratic Things' to Stop 'Existential Threat' Donald Trump
- 2. Real world prevalence of pelvic lymph node involvement in prostate cancer in Asia: do we need a rethink on normograms?
- 3. Candel Therapeutics to Host Investor Conference Call Featuring Expert Clinical Perspectives on CAN-2409 Phase 3 Prostate Cancer Data Following 2025 ASCO Presentation
- 4. Biden's presidential health reports showed no sign of recently revealed aggressive cancer
- 5. The epidemiology, etiology, and future prophylactic options for cancers in Mainland China
- 6. Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for CAN-2409 for the Treatment of Prostate Cancer
- 7. Tom Robbins, Versatile Muckraker for The Village Voice, Dies at 76
- 8. Brain Cancer Canada Awards $85K to Cutting-Edge Recurrent Glioblastoma Research
- 9. Editorial: Repurposed drugs targeting cancer signaling pathways: clinical insights to improve oncologic therapies, volume II
- 10. Intensity Therapeutics, Inc. to Collaborate with Author, Model, Executive Producer, Speaker and Breast Cancer Survivor Christine Handy to Raise Patient Awareness of Early-Stage Breast Cancer Treatment Options on the Horizon
Last updated at 12:45 GMT
Hot News Makers
Health/Pharma Companies
-
61578.80
-
14388.73
-
11414.74
-
10620.72
-
10025.17
-
8149.23
-
7367.41
-
6307.22
-
5990.08
-
5726.22
Drugs, Treatments, Trials
-
12207.75
-
11798.35
-
9808.87
-
7536.43
-
7282.40
-
6416.81
-
3208.23
-
1474.93
-
1410.38
-
1373.86
Last updated at 12:10 GMT
